Treace Medical Concepts Ownership | Who Owns Treace Medical Concepts?


OverviewForecastRevenueFinancialsChartTranscripts

Treace Medical Concepts Ownership Summary


Treace Medical Concepts is owned by 60.96% institutional investors, 25.64% insiders, and 13.40% retail investors. Armistice capital is the largest institutional shareholder, holding 9.94% of TMCI shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.34% of its assets in Treace Medical Concepts shares.

TMCI Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTreace Medical Concepts60.96%25.64%13.40%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryMedical Device Stocks52.08%10.61%37.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Armistice capital6.26M9.94%$36.81M
Blackrock funding, inc. /de3.77M5.98%$22.15M
William blair investment management3.10M4.92%$18.23M
Vanguard group2.73M4.39%$20.33M
Gagnon securities2.25M3.57%$13.23M
Jpmorgan chase1.98M3.18%$14.71M
Cibc private wealth group1.69M2.68%$9.92M
Deutsche bank ag\1.29M2.07%$9.59M
D. e. shaw1.12M1.79%$8.30M
Geode capital management1.06M1.71%$7.91M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Gagnon advisors830.27K3.28%$4.88M
Gagnon securities2.25M2.69%$13.23M
Birchview capital, lp176.95K1.03%$1.04M
Armistice capital6.26M0.64%$36.81M
Parkman healthcare partners844.00K0.57%$4.96M
Paradigm capital management inc/ny268.16K0.08%$1.58M
William blair investment management3.10M0.05%$18.23M
Kornitzer capital management inc /ks365.39K0.04%$2.15M
Accredited investors100.00K0.03%$588.00K
Y-intercept (hong kong)232.41K0.03%$1.37M

Top Buyers

HolderShares% AssetsChange
Ubs group968.43K0.00%892.46K
Jpmorgan chase1.98M0.00%714.98K
Gagnon securities2.25M2.69%503.61K
Gagnon advisors830.27K3.28%340.38K
Paradigm capital management inc/ny268.16K0.08%268.16K

Top Sellers

HolderShares% AssetsChange
Soleus capital management---887.94K
Deutsche bank ag\1.29M0.00%-767.68K
Cibc private wealth group1.69M0.02%-606.00K
Driehaus capital management188.91K0.01%-279.36K
Lisanti capital growth---252.22K

New Positions

HolderShares% AssetsChangeValue
Paradigm capital management inc/ny268.16K0.08%268.16K$1.58M
Bnp paribas arbitrage, snc79.35K0.00%79.35K$590.38K
Norges bank65.80K0.00%65.80K$489.55K
Algert global32.88K0.00%32.88K$193.00K
Qube research17.41K0.00%17.41K$102.36K

Sold Out

HolderChange
Capital performance advisors llp-1.00
Ifp advisors-2.00
Nelson, van denburg & campbell wealth management group-24.00
Stephens consulting-45.00
Srs capital advisors-106.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025122-12.23%38,408,4971.36%601.67%67-4.29%38-13.64%
Mar 31, 20251391.46%37,892,3351.57%601.68%702.94%44-
Dec 31, 202461-55.47%19,442,402-50.47%310.79%34-48.48%13-72.34%
Sep 30, 20241375.38%39,250,171-1.08%631.54%66-29.79%4795.83%
Jun 30, 2024130-2.26%39,678,007-2.97%631.42%9444.62%24-47.83%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.46M2.34%-
Vanguard Total Stock Mkt Idx Inv1.43M2.26%-31.46K
iShares Russell 2000 ETF1.13M1.79%-21.52K
William Blair Small Cap Growth I1.07M1.69%6.82K
First Eagle Small Cap Opportunity I917.56K1.45%124.61K
First Eagle US Small Cap Strategy797.21K1.27%365.13K
Xtrackers MSCI World Swap ETF 1C788.48K1.25%-
JPMorgan US Small Company L558.82K0.89%-18.82K
Fidelity Small Cap Index493.16K0.78%-
Vanguard Institutional Extnd Mkt Idx Tr484.53K0.77%-220.79K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 17, 2025Scanlan Sean F. Chief Innovation OfficerSell$398.46K
Mar 04, 2025Treace John T. Chief Executive OfficerBuy$524.06K
Sep 16, 2024Treace John T. Chief Executive OfficerBuy$265.63K
Aug 15, 2024TREACE JAMES T-Buy$501.03K
Aug 14, 2024Treace John T. Chief Executive OfficerBuy$510.31K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q111
2024 Q4--
2024 Q33-
2024 Q217-

TMCI Ownership FAQ


Who Owns Treace Medical Concepts?

Treace Medical Concepts shareholders are primarily institutional investors at 60.96%, followed by 25.64% insiders and 13.40% retail investors. The average institutional ownership in Treace Medical Concepts's industry, Medical Device Stocks, is 52.08%, which Treace Medical Concepts exceeds.

Who owns the most shares of Treace Medical Concepts?

Treace Medical Concepts’s largest shareholders are Armistice capital (6.26M shares, 9.94%), Blackrock funding, inc. /de (3.77M shares, 5.98%), and William blair investment management (3.1M shares, 4.92%). Together, they hold 20.83% of Treace Medical Concepts’s total shares outstanding.

Does Blackrock own Treace Medical Concepts?

BlackRock is not among the top 10 institutional shareholders of Treace Medical Concepts.

Who is Treace Medical Concepts’s biggest shareholder by percentage of total assets invested?

Gagnon advisors is Treace Medical Concepts’s biggest shareholder by percentage of total assets invested, with 3.28% of its assets in 830.27K Treace Medical Concepts shares, valued at 4.88M$.

Who is the top mutual fund holder of Treace Medical Concepts shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Treace Medical Concepts shares, with 2.34% of its total shares outstanding invested in 1.46M Treace Medical Concepts shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools